Literature DB >> 29097363

Interrogation of the Atherosclerosis-Associated SORT1 (Sortilin 1) Locus With Primary Human Hepatocytes, Induced Pluripotent Stem Cell-Hepatocytes, and Locus-Humanized Mice.

Xiao Wang1, Avanthi Raghavan1, Derek T Peters1, Evanthia E Pashos1, Daniel J Rader1, Kiran Musunuru2.   

Abstract

OBJECTIVE: The noncoding single-nucleotide polymorphism rs12740374 has been hypothesized to be the causal variant responsible for liver-specific modulation of SORT1(sortilin 1) expression (ie, expression quantitative trait locus) and, by extension, the association of the SORT1 locus on human chromosome 1p13 with low-density lipoprotein cholesterol levels and coronary heart disease. The goals of this study were to compare 3 different hepatocyte models in demonstrating that the rs12740374 minor allele sequence is responsible for transcriptional activation of SORT1 expression. APPROACH AND
RESULTS: We found that although primary human hepatocytes of varied rs12740374 genotypes strongly replicated the SORT1 expression quantitative trait locus observed previously in whole-liver samples, a population cohort of induced pluripotent stem cell-derived hepatocyte-like cells poorly replicated the expression quantitative trait locus. In primary human hepatocytes from multiple individuals heterozygous at rs12740374, we used CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats-associated 9) to specifically target the rs12740374 minor allele sequence ex vivo, resulting in a reproducible reduction in SORT1 expression. We generated a locus-humanized transgenic mouse with a bacterial artificial chromosome bearing the human SORT1 locus with the rs12740374 minor allele. In this mouse model, we used CRISPR-Cas9 to target the rs12740374 minor allele sequence in the liver in vivo, resulting in a substantial reduction of hepatic SORT1 expression.
CONCLUSIONS: The rs12740374 minor allele sequence enhances SORT1 expression in hepatocytes. CRISPR-Cas9 can be used in primary human hepatocytes ex vivo and locus-humanized mice in vivo to interrogate the function of noncoding regulatory regions. Induced pluripotent stem cell-derived hepatocyte-like cells experience limitations that prevent faithful modelling of some hepatocyte expression quantitative trait loci.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  animals; coronary disease; gene expression; genotype; liver

Mesh:

Substances:

Year:  2017        PMID: 29097363      PMCID: PMC5746470          DOI: 10.1161/ATVBAHA.117.310103

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  20 in total

1.  Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery.

Authors:  E-Chiang Lee; Qi Liang; Hanif Ali; Luke Bayliss; Alastair Beasley; Tara Bloomfield-Gerdes; Laura Bonoli; Richard Brown; Jamie Campbell; Adam Carpenter; Sara Chalk; Alison Davis; Nick England; Alla Fane-Dremucheva; Bettina Franz; Volker Germaschewski; Helen Holmes; Steve Holmes; Ian Kirby; Miha Kosmac; Anais Legent; Hui Lui; Anais Manin; Siobhan O'Leary; Jemima Paterson; Rocco Sciarrillo; Anneliese Speak; Dominik Spensberger; Laura Tuffery; Nikole Waddell; Wei Wang; Sophie Wells; Vivian Wong; Andrew Wood; Michael J Owen; Glenn A Friedrich; Allan Bradley
Journal:  Nat Biotechnol       Date:  2014-03-16       Impact factor: 54.908

2.  Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export.

Authors:  Mads Kjolby; Olav M Andersen; Tilman Breiderhoff; Anja W Fjorback; Karen Marie Pedersen; Peder Madsen; Pernille Jansen; Joerg Heeren; Thomas E Willnow; Anders Nykjaer
Journal:  Cell Metab       Date:  2010-09-08       Impact factor: 27.287

3.  Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia.

Authors:  K Kozarsky; M Grossman; J M Wilson
Journal:  Somat Cell Mol Genet       Date:  1993-09

4.  CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report.

Authors:  Xiao Wang; Avanthi Raghavan; Tao Chen; Lyon Qiao; Yongxian Zhang; Qiurong Ding; Kiran Musunuru
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-03       Impact factor: 8.311

5.  Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes.

Authors:  M A Morsy; E L Alford; A Bett; F L Graham; C T Caskey
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

6.  Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing.

Authors:  Qiurong Ding; Alanna Strong; Kevin M Patel; Sze-Ling Ng; Bridget S Gosis; Stephanie N Regan; Chad A Cowan; Daniel J Rader; Kiran Musunuru
Journal:  Circ Res       Date:  2014-06-10       Impact factor: 17.367

7.  A gene expression atlas of the central nervous system based on bacterial artificial chromosomes.

Authors:  Shiaoching Gong; Chen Zheng; Martin L Doughty; Kasia Losos; Nicholas Didkovsky; Uta B Schambra; Norma J Nowak; Alexandra Joyner; Gabrielle Leblanc; Mary E Hatten; Nathaniel Heintz
Journal:  Nature       Date:  2003-10-30       Impact factor: 49.962

Review 8.  Pluripotent stem cell-derived hepatocyte-like cells.

Authors:  R E Schwartz; H E Fleming; S R Khetani; S N Bhatia
Journal:  Biotechnol Adv       Date:  2014-01-16       Impact factor: 14.227

9.  Mapping the genetic architecture of gene expression in human liver.

Authors:  Eric E Schadt; Cliona Molony; Eugene Chudin; Ke Hao; Xia Yang; Pek Y Lum; Andrew Kasarskis; Bin Zhang; Susanna Wang; Christine Suver; Jun Zhu; Joshua Millstein; Solveig Sieberts; John Lamb; Debraj GuhaThakurta; Jonathan Derry; John D Storey; Iliana Avila-Campillo; Mark J Kruger; Jason M Johnson; Carol A Rohl; Atila van Nas; Margarete Mehrabian; Thomas A Drake; Aldons J Lusis; Ryan C Smith; F Peter Guengerich; Stephen C Strom; Erin Schuetz; Thomas H Rushmore; Roger Ulrich
Journal:  PLoS Biol       Date:  2008-05-06       Impact factor: 8.029

10.  A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice.

Authors:  Yang Yang; Lili Wang; Peter Bell; Deirdre McMenamin; Zhenning He; John White; Hongwei Yu; Chenyu Xu; Hiroki Morizono; Kiran Musunuru; Mark L Batshaw; James M Wilson
Journal:  Nat Biotechnol       Date:  2016-02-01       Impact factor: 54.908

View more
  13 in total

1.  Functional Genomics and CRISPR Applied to Cardiovascular Research and Medicine.

Authors:  Fang Li; Jianting Shi; Hong S Lu; Hanrui Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-21       Impact factor: 8.311

Review 2.  Trouble With Tribbles-1.

Authors:  Kavita S Jadhav; Robert C Bauer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-06       Impact factor: 8.311

3.  FIVEx: an interactive eQTL browser across public datasets.

Authors:  Alan Kwong; Andrew P Boughton; Mukai Wang; Peter VandeHaar; Michael Boehnke; Gonçalo Abecasis; Hyun Min Kang
Journal:  Bioinformatics       Date:  2021-08-30       Impact factor: 6.931

4.  Multi-Omic Approaches to Identify Genetic Factors in Metabolic Syndrome.

Authors:  Karen C Clark; Anne E Kwitek
Journal:  Compr Physiol       Date:  2021-12-29       Impact factor: 8.915

5.  Confirmation of Causal rs9349379- PHACTR1 Expression Quantitative Trait Locus in Human-Induced Pluripotent Stem Cell Endothelial Cells.

Authors:  Xiao Wang; Kiran Musunuru
Journal:  Circ Genom Precis Med       Date:  2018-10

Review 6.  Annual Report on Sex in Preclinical Studies: Arteriosclerosis, Thrombosis, and Vascular Biology Publications in 2018.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-23       Impact factor: 8.311

Review 7.  Systems genetics applications in metabolism research.

Authors:  Marcus Seldin; Xia Yang; Aldons J Lusis
Journal:  Nat Metab       Date:  2019-10-21

8.  Enhancer polymorphisms at the IKZF1 susceptibility locus for acute lymphoblastic leukemia impact B-cell proliferation and differentiation in both Down syndrome and non-Down syndrome genetic backgrounds.

Authors:  Vincent U Gant; Jacob J Junco; Maci Terrell; Raushan Rashid; Karen R Rabin
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

9.  Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations.

Authors:  Charles P Fulco; Joseph Nasser; Thouis R Jones; Glen Munson; Drew T Bergman; Vidya Subramanian; Sharon R Grossman; Rockwell Anyoha; Benjamin R Doughty; Tejal A Patwardhan; Tung H Nguyen; Michael Kane; Elizabeth M Perez; Neva C Durand; Caleb A Lareau; Elena K Stamenova; Erez Lieberman Aiden; Eric S Lander; Jesse M Engreitz
Journal:  Nat Genet       Date:  2019-11-29       Impact factor: 38.330

10.  Prime editing in mice reveals the essentiality of a single base in driving tissue-specific gene expression.

Authors:  Pan Gao; Qing Lyu; Amr R Ghanam; Cicera R Lazzarotto; Gregory A Newby; Wei Zhang; Mihyun Choi; Orazio J Slivano; Kevin Holden; John A Walker; Anastasia P Kadina; Rob J Munroe; Christian M Abratte; John C Schimenti; David R Liu; Shengdar Q Tsai; Xiaochun Long; Joseph M Miano
Journal:  Genome Biol       Date:  2021-03-16       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.